ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Europe and Select International Territories

ADC Therapeutics is eligible to receive up to $435 million, including $55 million upfront, $50 million on first European Commission approval and up to approximately $330 million in additional regulatory and sales milestones ADC Therapeutics to receive royalties from mid-teens up to the mid-twenty percent of net sales in Sobi’s territories Sobi to cost-share in … [Read more…]

Slingshot Biosciences, Inc. Partners with OLS – OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy

EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with OLS – OMNI Life Science. OLS is your partner for solutions in Flow Cytometry, Cell Culture, Cell Counting, Imaging, and Cell Analysis. We offer innovative systems for the entire workflow of cell … [Read more…]

Steward Health Care Appoints Rubén José King-Shaw Jr to Its Board of Directors

DALLAS–(BUSINESS WIRE)–Steward Health Care, the nation’s largest physician-led health care network, today announced the appointment of Rubén José King-Shaw Jr to its Board of Directors. King-Shaw currently serves as Steward’s Executive Vice President & Chief Strategy Officer, where he has led a number of critical strategic acquisitions and divestitures including the sale of Steward Health … [Read more…]

Q-State Publishes New Research on ASOs in Ultra-rare Neurodegenerative Disorder

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of serious nervous system disorders, today announced the publication of new research describing the successful design, screening and characterization of splice modulating antisense oligonucleotides (ASOs) as a potential therapeutic approach for SPG49/HSAN9 (spastic paraplegia 49, more recently classified as … [Read more…]

Kezar Life Sciences to Present at the William Blair Biotech Focus Conference

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Noreen Roth Henig, M.D., Chief Medical Officer, will participate in a panel called “Developing Therapies Against Novel Targets in Autoimmune Diseases” at the William Blair Biotech Focus Conference … [Read more…]

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on July 7, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on October 14, 2022, to shareholders of record as of September 15, 2022. About Thermo Fisher Scientific Thermo Fisher … [Read more…]

IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2022 financial results before the market opens on Thursday, July 21, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted … [Read more…]

Filament Health Announces First Dosing in Groundbreaking FDA-Approved Psilocin Clinical Trial

​​The trial, conducted at UCSF’s TrPR Lab, is first to use naturally derived psychedelic drug candidates and first to directly administer psilocin, the active form of psilocybin SAN FRANCISCO–(BUSINESS WIRE)–$FH #MentalHealth—Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament”), a clinical-stage natural psychedelic drug development company, today announced the beginning of dosing in the first United States … [Read more…]

Life Sciences BC Announces 24th Annual Award Winners

VANCOUVER, British Columbia–(BUSINESS WIRE)–#LSBCawards–Life Sciences BC (LSBC) is pleased to announce the recipients of the 24th Annual Life Sciences BC Awards, presented by Farris. These awards recognize the achievements of individuals, companies, and organizations that have had success in advancing successful health innovations and contribute to BC’s life sciences ecosystem. According to the report B.C. … [Read more…]

CAAN and IIHAC announce One Vision – Many Paths: the 9th International Indigenous Pre-Conference on HIV and AIDS to address sustainable solutions for the global Indigenous HIV response

MONTRÉAL–(BUSINESS WIRE)–In a few short weeks, the international community of world leaders, scientists, researchers, community and civil society advocates, service providers, private sector, and philanthropic partners will gather in Montréal, Canada for the biennial International AIDS Conference (AIDS 2022; July 29 – Aug 2). As a vital and long-standing forerunning event, the 9th International Indigenous … [Read more…]